Colrain Capital
Boston, MAfiles as COLRAIN CAPITAL LLC
$295m in 25 US stocks at the end of 30 June 2026. The top 10 are 68.0% of the money. It changed about 14.2% of the portfolio this quarter.
Value
$295m
Stocks
25
Top 10 share
68.0%
Turnover
14.2%
What changed this quarter
New
Bought for the first time this quarter.
- SalesforceCRM1.0% of the fund
- Honeywell InternationalHON0.4% of the fund
- Honeywell AerospaceHONA0.3% of the fund
Added
Bought more of a stock they already held.
- ChevronCVX6.7% of the fund+2%
- NewmontNEM6.5% of the fund+8%
- VistraVST6.2% of the fund+6%
- Antero ResourcesAR5.1% of the fund+6%
- FiservFISV5.1% of the fund+59%
- Cigna GroupCI4.6% of the fund+2%
- QualcommQCOM4.4% of the fund+4%
- MosaicMOS4.1% of the fund+15%
- Bristol-Myers SquibbBMY4.1% of the fund+3%
- SLB LimitedSLB3.7% of the fund+4%
- AptivAPTV3.6% of the fund+301%
- MedtronicMDT3.5% of the fund+26%
- ComcastCMCSA3.1% of the fund+12%
Cut
Sold some of their stake.
- VicorVICR19.3% of the fund-25%
- AlphabetGOOGL5.0% of the fund-3%
- Bunge Global SABG2.0% of the fund-8%
- EOG ResourcesEOG0.3% of the fund-40%
- Berkshire HathawayBRK-B0.1% of the fund-86%
- AppleAAPL<0.1% of the fund-10%
Sold out
Sold their entire stake.
- Honeywell InternationalHON-100%
- AdobeADBE-100%
- VersigentVGNT-100%
- International PaperIP-100%
Holdings
- NutrienNTR
- Share
- 3.5%
- Value
- $10m
- Shares
- 163,823
Held
- Honeywell AerospaceHONA
- Share
- 0.3%
- Value
- $1m
- Shares
- 4,650
New
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| VicorVICR | 19.3% | $57m | 150,277 | -25% |
| ChevronCVX | 6.7% | $20m | 119,041 | +2% |
| NewmontNEM | 6.5% | $19m | 204,381 | +8% |
| VistraVST | 6.2% | $18m | 115,429 | +6% |
| CVS HealthCVS | 5.2% | $15m | 148,962 | Held |
| Antero ResourcesAR | 5.1% | $15m | 430,421 | +6% |
| FiservFISV | 5.1% | $15m | 304,259 | +59% |
| AlphabetGOOGL | 5.0% | $15m | 41,430 | -3% |
| Cigna GroupCI | 4.6% | $13m | 48,944 | +2% |
| QualcommQCOM | 4.4% | $13m | 69,658 | +4% |
| MosaicMOS | 4.1% | $12m | 576,178 | +15% |
| Bristol-Myers SquibbBMY | 4.1% | $12m | 208,145 | +3% |
| SLB LimitedSLB | 3.7% | $11m | 235,875 | +4% |
| AptivAPTV | 3.6% | $11m | 173,500 | +301% |
| MedtronicMDT | 3.5% | $10m | 132,354 | +26% |
| NutrienNTR | 3.5% | $10m | 163,823 | Held |
| ComcastCMCSA | 3.1% | $9m | 371,600 | +12% |
| AbbVieABBV | 2.1% | $6m | 25,047 | Held |
| Bunge Global SABG | 2.0% | $6m | 53,993 | -8% |
| SalesforceCRM | 1.0% | $3m | 18,770 | New |
| Honeywell InternationalHON | 0.4% | $1m | 4,650 | New |
| Honeywell AerospaceHONA | 0.3% | $1m | 4,650 | New |
| EOG ResourcesEOG | 0.3% | $975,310 | 7,518 | -40% |
| Berkshire HathawayBRK-B | 0.1% | $329,757 | 659 | -86% |
| AppleAAPL | <0.1% | $260,424 | 900 | -10% |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 127.9% since 30 June 2025.
Where the money is
Industrials20.0%
Health care19.5%
Energy15.9%
Materials14.1%
Media & telecom8.1%
Utilities6.2%
Technology5.4%
Financial services5.2%
Retail & consumer3.6%
Everyday goods2.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.